Lintaz 4.5 GM Injection
Lintaz 4.5 is a powerful combination of Piperacillin (a broad-spectrum penicillin antibiotic) and Tazobactam (a β-lactamase inhibitor), used for treating moderate to severe infections caused by susceptible organisms. It is particularly effective in hospital-acquired and complicated infections due to its broad spectrum and β-lactamase inhibition. Lintaz is widely used in ICU and hospital settings for its potent efficacy against gram-positive and gram-negative organisms, including Pseudomonas aeruginosa.
Share Now
Additional Information
| Name | Lintaz 4.5 |
| Description | Lintaz 4.5 is a combination of Piperacillin and Tazobactam, used for moderate to severe infections caused by β-lactamase-producing bacteria. It is administered via IV and is effective in hospital-acquired pneumonia, intra-abdominal infections, and septicemia. |
| Active Ingredient | Piperacillin 4 g + Tazobactam 0.5 g |
| Indication | Nosocomial pneumonia, Complicated intra-abdominal infections, Septicemia, UTIs, Skin & soft tissue infections, Gynecological infections, Febrile neutropenia (empirical use) |
| Strengths | Injection vial: Piperacillin 4 g + Tazobactam 0.5 g For IV use only |
Related Products
Related products
Disclaimer
Pharma Solution is the marketing agent and Distributor for the listed products for the Gulf and MENA region. The products are either registered and approved by the respective local health authority or contracted by the MAH to supply to the end users on a named patient basis. Some products such as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.